In vivo, we demonstrated that serum IL-6 concentration in mice showed a stronger correlation with αSMA positive IHC than with tumor weight, indicating that the amount of IL-6-producing CAFs in the TME influences tumor development. The gene discussed is ACTA1; the disease is neoplasm.